Malaria remains one of the most important infectious diseases worldwide considering that 40% of the world’s population live in health risk areas and millions of febrile episodes due to malaria infection occur annually in children under the age of five in Africa alone and almost 3 million patients, primarily children, die each year. Among the various measures envisaged, to contain the disease, the concept of a vaccine to protect humans against malaria appears particularly attractive. The development of an effective malaria vaccine represents one of the most important approaches to provide cost-effective intervention, in addition to currently available malaria control strategies. Here, we review malaria as a public health problem and the status and promise in malaria vaccine development.
Recurrent boils are troublesome enough to children and their parents to be finally referred to the paediatricians. This study attempts to provide local data on epidemiology, pattern of infections of offending organism especially Staphylococcus aureus and underlying immunological abnormality. This condition does not appear to be related to socio economic status nor is staphylococcal nasal cariage a direct contributing factor. Defect in neutrophil function especially the respiratory burst assayed via chemiluminescence response to Staphylococcus aureus is closely associated with this condition. It is hoped that this data would be a further impetus for further research into this exciting field.